Respiratory Tract Infections News and Research

RSS

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

The use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria.

27 Sep 2023

Most infants admitted to ICU for RSV were previously healthy, study finds

Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.

16 Aug 2023

RSV vaccine recommendation rates increase when people are informed about FDA approval process

A new study finds that people are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from RSV illness if they are shown a chart outlining the rigorous process a vaccine undergoes to be approved by the Food and Drug Administration (FDA).

9 Aug 2023

The immunomodulatory and antiviral function of vitamin D

Vitamin D's immunomodulatory and antiviral function.

4 Aug 2023

The number of deaths attributable to second hand smoke exposure has increased between 1990 and 2019

Researchers estimated the prevalence of and assessed trends in exposure to second-hand smoke (SHS)

2 Aug 2023

Machine learning's potential for rapid LRTI diagnosis

A team of researchers evaluated the use of prediction models in LRTI diagnosis.

17 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Medicaid Expansion led to increased access to preventive care for low-income adults

People with low incomes who live in states that expanded Medicaid got more of the kind of health care that can keep them healthier in the long run, compared with similar people in non-expansion states, a new study finds.

7 Jul 2023

Global efforts to reduce infectious diseases must include older children and adolescents

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.

4 Jul 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals

A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points, from 43% to 25%, across two large Los Angeles safety net hospitals.

12 Jun 2023

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Researchers investigated the prevalence of human metapneumovirus through 2020 considering the implementation of NPIs due to the COVID-19 pandemic.

31 May 2023

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine.

30 May 2023

What is the subsequent risk of mental disorders among individuals with SARS-CoV-2 infection, and are the associations specific for COVID-19?

Researchers estimated psychiatric disorders and psychotropic medication usage risks among SARS-CoV-2-infected.

30 May 2023

Ethanol vapor inhalation can disable influenza A virus in mice

Inhaling low concentrations of ethanol vapor can disable the influenza A virus in mice, without harmful side effects, says a new study by scientists at the Okinawa Institute of Science and Technology (OIST). The scientists believe it may also treat similar viruses such as the one that causes Covid-19.

27 Apr 2023

Respiratory Tract Infections News and Research

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

Most infants admitted to ICU for RSV were previously healthy, study finds

RSV vaccine recommendation rates increase when people are informed about FDA approval process

The immunomodulatory and antiviral function of vitamin D

The number of deaths attributable to second hand smoke exposure has increased between 1990 and 2019

Machine learning's potential for rapid LRTI diagnosis

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Medicaid Expansion led to increased access to preventive care for low-income adults

Global efforts to reduce infectious diseases must include older children and adolescents

Battle against RSV: Computational design paves way for new polyvalent vaccine

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

What is the subsequent risk of mental disorders among individuals with SARS-CoV-2 infection, and are the associations specific for COVID-19?

Ethanol vapor inhalation can disable influenza A virus in mice

Soaring healthcare costs for RSV-related complications in US seniors 60 plus

The economic burden of RSV infections in low and middle-income countries

New method for lower respiratory tract infection diagnosis in critically ill children

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Latest News